Labiotech.eu

News and Trends 2 Jun 2016

A ‘Skin Spray’ could cure Chronic Skin Wounds caused by Diabetes

Avita has initiated a trial in the UK to evaluate the potential of its ReGenerCell technology to treat diabetic foot ulcers, a skin wound that can be very hard to treat. With offices in the UK and originally from Australia, Avita Medical is developing products in tissue engineering and regenerative medicine. Its technology utilises the […]

June 2, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 1 Jun 2016

Novel Bionic Vision device gains approval for clinical trials in Renowned UK Hospital

Pixium Vision will be testing its new IRIS II bionic vision system in a clinical trial. The device can mimic eye function in people affected by Retinitis pigmentosa and Macular degeneration. Based in Paris (France), Pixium Vision is developing an alternative for people who have lost their sight – a bionic vision restoration system (VRS). One […]

June 1, 2016 - 2 minutesmins - By Denise Neves Gameiro

gene therapy strimvelis biotech gsk offerele ada scid child

News and Trends 1 Jun 2016

EMA approves Groundbreaking Gene Therapy for Super Rare ‘Bubble Baby’ Disease

GSK, Fondazione Telethon and Ospedale San Raffaele have announced that the EMA has approved Strimvelis for a super rare immunodeficiency disease in Children. Following 20 years of research at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) in Italy, this is the news patients have been waiting for. Strimvelis is the first ex vivo stem cell gene […]

June 1, 2016 - 3 minutesmins - By Dani Bancroft

crispr therapeutics gene editing labiotech refresh philip hemme biotech roger novak

News and Trends 1 Jun 2016

CRISPR Thx’ Founder: “We have over $250M in the bank”

So begins our series of videos documenting our biotech conference premier – Labiotech Refresh. Here Philip spoke with Rodger Novak, the CEO and founder of CRISPR Therapeutics, which is leading the biotech front on Gene Editing in Europe. Having the CEO of CRISPR Therapeutics come and speak at our first event was really exciting for […]

June 1, 2016 - 2 minutesmins - By Dani Bancroft

circassia grass allergy peptide spire trial

News and Trends 31 May 2016

UK Immunotherapy against Grass Allergies moves on to Phase III Trials

Circassia is beginning a Phase III trial for its short-course immunotherapy for grass allergies. This common type of allergy can significantly impact the life quality of patients. Circassia is based in Oxford (UK) and was part of 2014’s record Biotech IPOs – raising a whopping €268M. It focuses on respiratory diseases, such as asthma and allergies. Its […]

May 31, 2016 - 2 minutesmins - By Denise Neves Gameiro

Springwave spirulina algae microalgae biotech drink hong kong facebook drink algama

News and Trends 31 May 2016

Asian Super investor claims stake in Microalgae Drink Startup

The French startup Algama has received €3.5M investment from the Hong Kong billionaire, Li Ka-shing, known for his stakes in Facebook, Spotify, and Skype. Based on a microalgae brew, Algama’s nutritional drinks product SpringWave is evidently hitting the marketing mark, by making the algae Spirulina a tasty. But there are many other algae-based products which look to compete in this Omega-3 and […]

May 31, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 31 May 2016

DBV Technologies: “This is our First and most Significant Partnership signed”

The billion-euro Biotech from Paris DBV Technologies just signed a €100M deal with Nestlé Health Science to develop a new diagnostic test of Milk allergies. This is the first deal of DBV and shows the potential of its technological platform. I had a chat with its COO David Schilansky to find out more… DBV is […]

May 31, 2016 - 4 minutesmins - By Philip Hemme

roche diabetes senseonics fluorescent sensor

News and Trends 30 May 2016

Roche debuts new MedTech for needle-free management of Diabetes

Roche is making progress in its Diabetes Care unit. It has struck a deal with the MedTech company Senseonics to sell an implantable glucose sensor in some major European countries. The Diabetes Care division of Swiss big Pharma Roche has more than 35 years of experience, and its Accu-Check devices are one of best-selling diabetes management […]

May 30, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 30 May 2016

Besides Techno, Berlin is also the place to be for Life Science Industries

On the 25th of May, the largest network event for life sciences and healthcare industries in the German capital region once again came to life for the 14th time, for Bionnale 2016 . As we too belong to this city, we are pleased to summarise the highlights of what happened there… This free event, which belongs to the Life Science’s […]

May 30, 2016 - 3 minutesmins - By Jerome Topsent

carbios bioplastic bio recycling biodegradation

News and Trends 30 May 2016

French Biodegradable Plastics get 2 new key US Patents

Carbios has been granted two key US patents: One for a novel plastic-degrading microorganism, and another for the creation of plastics with a customised lifespan – which could help bioplastics break into more industrial applications. A Green Chemistry company from the French region of Auvergne, Carbios was founded in 2011 but already has had some major […]

May 30, 2016 - 3 minutesmins - By Denise Neves Gameiro

nasdaq merus biotech ipo closing immunooncology cancer breast ovarian colorectal finance

News and Trends 30 May 2016

Dutch Immuno-Oncology Biotech closes massive IPO on the NASDAQ

The Utrecht based Merus has snagged around $47.3M (€42.5M) in an IPO on the NASDAQ market for its portfolio of antibodies targeting breast and colorectal cancers. Back in April 2015, Merus announced its intention to go public on the Nasdaq, with the goal of raising at least €100M for the rest of the year, but […]

May 30, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 28 May 2016

What Happened this Week? Refresh, Virtual Biotech, Bayer and Monsanto

1. So that was Labiotech Refresh! Here are the conference Highlights 2. To Be – or Not To Be, a Virtual Biotech? 3. Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased… 4. Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex 5. French T-cell Expert restarts trial for Crohn’s after Manufacturing Hiccup […]

May 28, 2016 - 1 minutemin - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

A ‘Skin Spray’ could cure Chronic Skin Wounds caused by Diabetes

Novel Bionic Vision device gains approval for clinical trials in Renowned UK Hospital

EMA approves Groundbreaking Gene Therapy for Super Rare ‘Bubble Baby’ Disease

CRISPR Thx’ Founder: “We have over $250M in the bank”

UK Immunotherapy against Grass Allergies moves on to Phase III Trials

Asian Super investor claims stake in Microalgae Drink Startup

DBV Technologies: “This is our First and most Significant Partnership signed”

Roche debuts new MedTech for needle-free management of Diabetes

Besides Techno, Berlin is also the place to be for Life Science Industries

French Biodegradable Plastics get 2 new key US Patents

Dutch Immuno-Oncology Biotech closes massive IPO on the NASDAQ

What Happened this Week? Refresh, Virtual Biotech, Bayer and Monsanto

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!